{
    "code": "01046869",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01046869",
    "time": "2019-09-20 03:10:03",
    "許可證字號": "衛署藥製字第046869號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "114\/01\/07",
    "發證日期": "94\/01\/07",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00104686907",
    "中文品名": "格比平注射劑0.2毫克\/毫升",
    "英文品名": "GLYCOPYRODYN INJECTION 0.2MG\/ML",
    "適應症": "手術前或手術中用以減少唾液、支氣管、咽囊分泌物，和胃分泌之游離酸；麻醉或插管治療時用以阻斷心臟迷走神經反射作用、消化性潰瘍之輔助治療。",
    "劑型": "270注射劑",
    "包裝": "1毫升安瓿 100支以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "GLYCOPYRROLATE",
    "主製造廠": {
        "申請商名稱": "0939101200  科進製藥科技股份有限公司",
        "申請商地址": "台北市南港區園區街3號14樓之7",
        "主製造廠": "",
        "製造廠名稱": "6133061495  聯亞藥業股份有限公司新竹廠"
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208002400",
            "成分名稱": "GLYCOPYRROLATE",
            "含量描述": "",
            "含量": "0.2000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "藥製046869_仿單-104-10-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01046869&Seq=005&Type=9"
        },
        {
            "title": "Glycopyrodyn Injection 0.2mg per ml Label-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01046869&Seq=007&Type=8"
        }
    ]
}